Parallel decrease in neurotoxin quinolinic acid and soluble tumor necrosis factor receptor p75 in serum during highly active antiretroviral therapy of HIV type 1 disease. [electronic resource]
Producer: 20000927Description: 1215-21 p. digitalISSN:- 0889-2229
- Adult
- Aged
- Aged, 80 and over
- Anti-HIV Agents -- therapeutic use
- Antigens, CD -- blood
- Drug Therapy, Combination
- Female
- HIV Infections -- drug therapy
- HIV-1 -- physiology
- Humans
- Kynurenine -- blood
- Male
- Middle Aged
- Quinolinic Acid -- blood
- RNA, Viral -- blood
- Receptors, Tumor Necrosis Factor -- blood
- Receptors, Tumor Necrosis Factor, Type II
- Reverse Transcriptase Inhibitors -- therapeutic use
- Treatment Outcome
- Tryptophan -- blood
- Viral Load
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.